Pharmacology
#B-352 | (R)(+)-Bay K8644 | Blocker | CaV1.2 #L-110 | L-651,582 | Blocker | CaV1.2 #B-350 | (±)-Bay K8644 | Activator | CaV1.2 #B-351 | (S)(-)-Bay K8644 | Activator | CaV1.2 #F-160 | FPL 64176 | Activator | CaV1.2 #S-105 | SR 33805 oxalate | Blocker | CaV1.2 #C-135 | Cilnidipine | Blocker | CaV1.2 #L-125 | Lomerizine dihydrochloride | Blocker | CaV1.2 #B-120 | Benidipine hydrochloride | Blocker | CaV1.2 #L-125 | Lomerizine dihydrochloride | Blocker | CaV1.2 #I-100 | Isradipine | Blocker | CaV1.3 #G-140 | GV-58 | Activator | CaV2.1 #F-120 | FTX-3.3 | Blocker | CaV2.1 #F-130 | sFTX-3.3 | Blocker | CaV2.1 #E-155 | Eliprodil | Blocker | CaV2.1 #P-105 | PD 173212 | Blocker | CaV2.2 #C-135 | Cilnidipine | Blocker | CaV2.2 #E-155 | Eliprodil | Blocker | CaV2.2 #T-140 | TTA-A2 | Blocker | CaV3.1 #B-120 | Benidipine hydrochloride | Blocker | CaV3.1 #T-155 | TTA-P2 | Blocker | CaV3.2 #N-206 | NNC 55-0396 dihydrochloride hydrate | Blocker | CaV3.2 #T-210 | TTA-P2 (S-enantiomer) | Blocker | CaV3.2 #M-165 | ML 218 | Blocker | CaV3.2 #M-166 | ML 218 hydrochloride | Blocker | CaV3.2 #L-140 | L-Ascorbic acid | Blocker | CaV3.2 #M-150 | Mibefradil dihydrochloride hydrate | Blocker | CaV3.2
Dynamic News About Categories Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Dynamic Tips Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.